Thousands of Australian high school students will have access to a new version of Merck’s highly controversial, genetically engineered HPV vaccine starting in 2018.
The new Gardasil 9 vaccine claims to protect against nine different strains of HPV and to prevent 90 percent of the virus strains that contribute to cervical cancer. Vaccine makers also claim the new vaccine will offer protection against anal, vulvar and throat cancers caused by HPV, as well as genital warts.
While Gardasil 9 claims to prevent 90 per cent of the HPV strains that contribute to cervical cancer, the math just doesn’t add up. The World Health Organization states that there are over 100 types of HPV, of which AT LEAST 13 are cancer causing. So even if the vaccine protected against nine strains, that would only equate to 67 percent coverage of cancerous strains. So much for that 90 percent!
Here’s the real question- Does Gardasil actually provide protection against cervical cancer at all? Science shouts a resounding, “NO!” According to the Annals of Medicine, “At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination.”
In addition to having no proven efficacy, Gardasil has plenty of horrific side effects including peripheral nervous system damage and sensory and motor syndromes. One 2009 study performed by neurologist Dr. Ian Sutton showed five cases of multiple sclerosis-like symptoms emerging shortly after women received the Gardasil vaccine, observing:
“We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil. Although the target population for vaccination, young females, has an inherently high risk for MS, the temporal association with demyelinating events in these cases may be explained by the potent immuno-stimulatory properties of HPV virus-like particles which comprise the vaccine.”
As of October 5, 2017, there have been 59,963 serious adverse reactions reported to VAERS since Gardasil first hit the market in 2007. These reactions include 311 deaths and 1,767 disabilities which equals about 31 deaths and 176 disabilities per year. In fact, in 2013, the National Vaccine Injury Compensation Program paid out just under $6 Million to 49 Gardasil victims with varying injuries, including 26 deaths.
Also unfortunate is the fact that, according to this study, nearly one in four girls who receive the HPV vaccine mistakenly believe that their risk for contracting other STD’s, like syphilis and gonorrhea, is reduced.
And let us not forget that this vaccine is being brought to us by the same people who gave us Vioxx. As you may recall, Vioxx is the drug that caused 88,000 heart attacks and killed 38,000 people before Merck was forced to remove the drug from the market in 2004.
No proven efficacy, horrific side effects and genetically engineered ingredients, and to top it all off, the CDC openly admits that most cases of HPV (90 percent) clear up on their own with no lasting health issues.
It’s safe to say that young girls are better off sticking to barrier methods to prevent HPV infection.